Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-20

Clinical Trial Update: A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of DA-1241 in healthy male subjects. The list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DA-1241

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED